BCL2L1 and diabetes mellitus: According to the results presented here, these new compounds may thus represent therapeutic options to interfere with the production of the alternative pro-apoptotic Bcl-xS isoform whose overexpression has been linked to various disorders such as some forms of diabetes in which it has been associated to exacerbated apoptosis of β cells in the islets of Langerhans (15).